Soticlestat
- Product Name
- Soticlestat
- CAS No.
- 1429505-03-2
- Chemical Name
- Soticlestat
- Synonyms
- OV935;TAK-935;Soticlestat;Soticlestat??(TAK-935;Soticlestat/TAK-935/OV935;Soticlestat, 10 mM in DMSO;2,4’-Bipyridin]-3-yl(4-benzyl-4-hydroxy-1-piperidyl)methanone;2,4'-Bipyridin]-3-yl(4-benzyl-4-hydroxypiperidin-1-yl)methanone;[2,4'-Bipyridin]-3-yl(4-benzyl-4-hydroxypiperidin-1-yl)methanone;Methanone, [2,4'-bipyridin]-3-yl[4-hydroxy-4-(phenylmethyl)-1-piperidinyl]-
- CBNumber
- CB54668528
- Molecular Formula
- C23H23N3O2
- Formula Weight
- 373.45
- MOL File
- 1429505-03-2.mol
Soticlestat Property
- solubility
- DMSO: soluble
- form
- A solid
- color
- White to off-white
N-Bromosuccinimide Price
- Product number
- CS-0078356
- Product name
- Soticlestat
- Packaging
- 5mg
- Price
- $200
- Updated
- 2021/12/16
- Product number
- CS-0078356
- Product name
- Soticlestat
- Packaging
- 10mg
- Price
- $350
- Updated
- 2021/12/16
- Product number
- CS-0078356
- Product name
- Soticlestat
- Packaging
- 25mg
- Price
- $650
- Updated
- 2021/12/16
- Product number
- orb573114
- Product name
- Soticlestat
- Purity
- >98%
- Packaging
- 10mg
- Price
- $690.2
- Updated
- 2021/12/16
- Product number
- CS-0078356
- Product name
- Soticlestat
- Packaging
- 50mg
- Price
- $950
- Updated
- 2021/12/16
Soticlestat Chemical Properties,Usage,Production
Uses
Soticlestat (TAK-935; OV935) is a first-in-class, potent, selective, and orally active cholesterol 24-hydroxylase (CH24H) inhibitor. Soticlestat has the potential for epilepsy syndromes research[1][2].
in vivo
Soticlestat treatment lowers brain 24S-hydroxycholesterol in a dose-dependent manner and substantially reduceds premature deaths of APP/PS1-Tg mice at a dose lowering brain 24S-hydroxycholesterol by approximately 50%. Soticlestat can suppress potassium-evoked extracellular glutamate elevations in the hippocampus[1].
| Animal Model: | Amyloid precursor protein and presenilin 1 (APP/PS1-Tg) mice (7-week-old)[1] |
| Dosage: | 10 mg/kg |
| Administration: | Oral administration; once daily; for 1 days, 3 days and 7 days |
| Result: | Lowered brain 24S-hydroxycholesterol in a dose-dependent manner and substantially reduced premature deaths of APP/PS1-Tg mice at a dose lowering brain 24S-hydroxycholesterol by approximately 50%. |
References
[1] Toshiya Nishi, et al. Soticlestat, a novel cholesterol 24-hydroxylase inhibitor shows a therapeutic potential for neural hyperexcitation in mice. Sci Rep. 2020 Oct 13;10(1):17081. DOI:10.1038/s41598-020-74036-6
[2] Krista Eschbach, et al. Stiripentol for the treatment of seizures in Dravet syndrome. Expert Rev Clin Pharmacol. 2019 May;12(5):379-388. DOI:10.1080/17512433.2019.1605904
Soticlestat Preparation Products And Raw materials
Raw materials
Preparation Products
Soticlestat Suppliers
- Tel
- +1-781-999-5354; +17819995354
- marketing@targetmol.com
- Country
- United States
- ProdList
- 32435
- Advantage
- 58
- Tel
- +1-708-310-1919 +1-13798911105
- Fax
- 708-557-7486
- sales@invivochem.cn
- Country
- United States
- ProdList
- 6391
- Advantage
- 58
- Tel
- +1-781-999-5354;
- support@targetmol.com
- Country
- United States
- ProdList
- 39035
- Advantage
- 58
- Tel
- --
- Fax
- --
- cayman@caymanchem.com
- Country
- United States
- ProdList
- 6213
- Advantage
- 81